7Nakaqawa Y,Suzuki K,Hirose T. Clinical efficacy and safety of biapenem for febrile neutropenia in patients with underlying hematopoietic diseases:a multi-institutional study[J].Journal of Infection and Chemotherapy,2011,(01):58-67.
8Gomi K,Fujimura S,Fuse K. Antibacterial activity of carbapenems against clinical isolates of respiratory acterial pathogens in the northeastern region of Japan in 2007[J].Journal of Infection and Chemotherapy,2011,(02):200-206.
9Jia B,Lu P,Huang W. A multicenter,randomized controlled clinical study on biapenem and imipenem/cilastatin injection in the treatment of respiratory and urinary tract infections[J].Chemotherapy,2010,(04):285-290.
8Sarker SD,Nahar L,Kumarasamy Y.Microtitre plate-based antibacterial assay incorporating resazlnin as an indicator of cell growth,and its application in the in vitro antibacterial screening of phytochcmicals[J].Methods,2007,42:321-324.
9Malanosld GJ,Collins L,Wennersten C,et al.In vitro actitivy of biapenem against clinical isolates of gram-positive and gramnegitive bacteria[J].Antimicrob Agents Chemother,1993,37(9):2 009-2 016.
